Mostrando 2 resultados de: 2
Hepatic parenchymal cell and mitochondrial-targeted astaxanthin nanocarriers for relief of high fat diet-induced nonalcoholic fatty liver disease
ArticleAbstract: Nonalcoholic fatty liver disease (NAFLD) is a metabolic syndrome disorder. Here, hepatic parenchymalPalabras claves:Autores:Che T., Mingqian Tan, Song Y., Su W., Wang H., Xing S.Fuentes:scopusOrally deliverable sequence-targeted astaxanthin nanoparticles for colitis alleviation
ArticleAbstract: Orally targeted strategy of anti-inflammatory agents has attracted tremendous attention for reducingPalabras claves:Macrophages, Mitochondria, Oral administration, Sequence-targeted, Ulcerative ColitisAutores:Chen Y., Cui W., Hua Z., Mingqian Tan, Su W., Tie S., Yu X., Zhang L.Fuentes:scopus